ESC Professional Premium Access

Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.

Congress Presentation

About the speaker

Doctor Katsuomi Iwakura

Sakurabashi-Watanabe Hospital, Osaka (Japan)
0 follower

7 more presentations in this session

Impact of diabetes and glucose-lowering therapy on post-operative atrial fibrillation after cardiac surgery: secondary analysis of the SEARCH-AF CardioLink-1 randomized clinical trial

Speaker: Mr A. Pandey (Hamilton, CA)

Thumbnail

Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation

Speaker: Doctor R. Nishinarita (Nerima, JP)

Thumbnail

Sodium-glucose cotransporter 2 inhibitors not only suppress recurrence after atrial fibrillation ablation but also cause atrial reverse remodeling

Speaker: Associate Professor T. Mine (Nishinomiya, JP)

Thumbnail

Prognosis of atrial fibrillation with or without comorbidities. Analysis of younger adults from a nationwide database

Speaker: Professor L. Fauchier (Tours, FR)

Thumbnail

Influence of obesity and overweight on the association between sleep-disordered breathing and atrial fibrillation: the DASAP-HF study

Speaker: Professor G. Boriani (Modena, IT)

Thumbnail

Access the full session

Atrial fibrillation in context of concomitant medical conditions

Speakers: Doctor K. Iwakura, Mr A. Pandey, Doctor R. Nishinarita, Associate Professor T. Mine, Professor L. Fauchier...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb